Genetics and pathogenesis of ankylosing
People with long-term Ankylosing
Spondylitis are at increased risk of spinal fractures and osteoporosis which eventually leads to severe nerve damage.
Thirdly, AS patients with active disease (Bath Ankylosing
Spondylitis Disease Activity Index >4) were included in the study.
Abnormal autonomic cardiovascular control in ankylosing
An update on the use of tumor necrosis factor alpha inhibitors in the treatment of ankylosing
spondylitis is not normally associated with quadriceps degeneration to such an extent that it can cause rupture as was seen in the case reported herein.
Identification of multiple risk variants for ankylosing
spondylitis through high-density genotyping of immune-related loci.
spondylitis: Clinical features of ankylosing
The report reviews pipeline therapeutics for Ankylosing
Spondylitis (Bekhterev's Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources
KEY WORDS: Ankylosing
Spondylitis, Spondyloarthropathy, Extra-articular features.
All patients met the diagnostic criteria of Ankylosing
Spondylitis and had been followed by a rheumatologist on a routine basis.
This report provides comprehensive information on the therapeutic development for Ankylosing
Spondylitis (Bekhterev's Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
DENVER -- Even as prescribing of tumor necrosis factor inhibitors for patients with ankylosing
spondylitis climbed in the last half-dozen years, patients' use of prescription narcotics increased as well.
spondylitis is a chronic inflammatory disease that predominantly affects the dorsal column, the inflammatory process starting frequently at the level of sacroiliac joints and progressing upwardly.
8 mL (adalimumab; [genetical recombination], "HUMIRA"), a fully human anti-TNF-alpha monoclonal antibody formulation, has been lifted for use in patients with ankylosing